Document is current
Any future updates will be listed below
-
Authors
McCracken, Celeste http://orcid.org/0000-0003-1285-2393
Raisi-Estabragh, Zahra
Szabo, Liliana
Robson, John
Raman, Betty
Topiwala, Anya
Roca-Fernández, Adriana
Husain, Masud
Petersen, Steffen E.
Neubauer, Stefan
Nichols, Thomas E.
-
Funding
Funding for this research was provided by:
NIHR Oxford Biomedical Research Centre (IS-BRC-1215-20008)
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 21 November 2023
First Online: 23 January 2024
Declarations
:
: This study complies with the Declaration of Helsinki; the work was covered by the ethical approval for UK Biobank studies from the National Health Service (NHS) National Research Ethics Service on 17 June 2011 (Ref 11/NW/0382) and extended on 18 June 2021 (Ref 21/NW/0157) with written informed consent obtained from all participants. This study was conducted under UK Biobank access application 59867.
: This study contains no identifying information for any person or persons. All UK Biobank have given consent for their data to be published as part of the general consent for UK Biobank registration.
: SEP provides consultancy to Cardiovascular Imaging Inc., Calgary, Alberta, Canada. BR consulted for Axcella Therapeutics. ARF is an employee and shareholder in Perspectum Ltd., Oxford, UK. SN is a founder, shareholder, and former board member of Perspectum. TEN provides consultancy to Perspectum Ltd., Oxford, UK. All other authors declare that they have no competing interests. The corresponding author attests that all listed authors meet the authorship criteria and that no others meeting the criteria have been omitted.
